Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight

BACKGROUND: Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal cells currently tested for multiple therapeutic purposes. Their potential to home into tumors, to secrete trophic/vasculogenic factors, and to suppress immune response raises questions regarding their biosafety. Our aim...

Full description

Saved in:
Bibliographic Details
Published in:Stem Cell Res Ther
Main Authors: Bruna, Flavia, Plaza, Anita, Arango, Martha, Espinoza, Iris, Conget, Paulette
Format: Artigo
Language:Inglês
Published: BioMed Central 2018
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5948822/
https://ncbi.nlm.nih.gov/pubmed/29751770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-018-0878-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items